Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Wesana Health Hldgs Inc (WSNAF)

Wesana Health Hldgs Inc (WSNAF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade WSNAF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0800 unch
on 09/23/22
0.1489 -46.27%
on 08/24/22
-0.0442 (-35.59%)
since 08/23/22
3-Month
0.0800 unch
on 09/23/22
0.1783 -55.13%
on 06/27/22
-0.0710 (-47.02%)
since 06/23/22
52-Week
0.0800 unch
on 09/23/22
2.9500 -97.29%
on 09/24/21
-2.5763 (-96.99%)
since 09/23/21

Most Recent Stories

More News
Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

His talk will kick-off the daylong biotechnology conference on cutting-edge therapies...

WESA.CN : 0.110 (-8.33%)
WSNAF : 0.0800 (-11.60%)
Wesana Announces First Quarter 2022 Financial Results

CHICAGO and TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven...

WESA.CN : 0.110 (-8.33%)
WSNAF : 0.0800 (-11.60%)
Wesana Health Outlines Accelerated Drug Development Pathway

CHICAGO and TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven...

WESA.CN : 0.110 (-8.33%)
WSNAF : 0.0800 (-11.60%)
Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its Clinics and Other Care Delivery Assets

CHICAGO and TORONTO, May 05, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven...

WESA.CN : 0.110 (-8.33%)
WSNAF : 0.0800 (-11.60%)
Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highlights

CHICAGO and TORONTO, May 02, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven...

WESA.CN : 0.110 (-8.33%)
WSNAF : 0.0800 (-11.60%)
Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat Major Depressive Disorder

Concurrently, the Company is launching a non-brokered private placement NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...

WESA.CN : 0.110 (-8.33%)
WSNAF : 0.0800 (-11.60%)
Wesana Health CEO Daniel Carcillo to Speak at Several Leading Investor and Industry Events

CHICAGO and TORONTO, March 29, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven...

WESA.CN : 0.110 (-8.33%)
WSNAF : 0.0800 (-11.60%)
Wesana Health Announces New Findings Indicating Psylocibin Potentiates Impact of an Anti-Depressant

CHICAGO and TORONTO, March 22, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven...

WESA.CN : 0.110 (-8.33%)
WSNAF : 0.0800 (-11.60%)
Wesana Health Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013

Pre-IND Meeting is a Significant Milestone in the Clinical Development of SANA-013, Defining the Pathway to Initiate in-Human Clinical Trials in Q4 2022...

WESA.CN : 0.110 (-8.33%)
WSNAF : 0.0800 (-11.60%)
Wesana Provides Updates on Build-out of Third Clinic

Naperville clinic to open Spring 2022...

WESA.CN : 0.110 (-8.33%)
WSNAF : 0.0800 (-11.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 0.0863
2nd Resistance Point 0.0851
1st Resistance Point 0.0825
Last Price 0.0800
1st Support Level 0.0787
2nd Support Level 0.0775
3rd Support Level 0.0749

See More

52-Week High 2.9500
Fibonacci 61.8% 1.8537
Fibonacci 50% 1.5150
Fibonacci 38.2% 1.1763
Last Price 0.0800
52-Week Low 0.0800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar